9 Meters Biopharma, Inc. Research and Development in Process
9 Meters Biopharma, Inc. reported Research and Development in Process of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-03-28
- 9 Meters Biopharma, Inc. research and development in process for the quarter ending 2022-12-31 was $0.00.
- 9 Meters Biopharma, Inc. research and development in process for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- 9 Meters Biopharma, Inc. research and development in process for the quarter ending 2021-12-31 was $0.00.
- 9 Meters Biopharma, Inc. research and development in process for the quarter ending 2021-09-30 was $5.10M.
- 9 Meters Biopharma, Inc. research and development in process for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- 9 Meters Biopharma, Inc. research and development in process for fiscal 2021 was $5.10M, a 84.18% decline from fiscal 2020.
- 9 Meters Biopharma, Inc. research and development in process for fiscal 2020 was $32.27M.
- 9 Meters Biopharma, Inc. research and development in process for fiscal 2019 was $0.00.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 10-K · filed 2023-03-28 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $5.10M derived: sum of 2 quarters · filed 2023-03-28 | $5.10M derived: sum of 3 quarters · filed 2023-03-28 | $5.10M 10-K · filed 2023-03-28 |
| 2021-09-30 | $5.10M 10-Q · filed 2022-11-08 | $5.10M derived: sum of 2 quarters · filed 2022-11-08 | $5.10M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $0.00 derived: sum of 2 quarters · filed 2022-03-23 | $32.27M derived: sum of 3 quarters · filed 2022-03-23 | $32.27M 10-K · filed 2022-03-23 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $32.27M derived: sum of 2 quarters · filed 2021-11-15 | $32.27M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $32.27M 10-Q · filed 2021-08-12 | $32.27M 10-Q · filed 2021-08-12 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $0.00 derived: sum of 2 quarters · filed 2021-03-22 | $0.00 derived: sum of 3 quarters · filed 2021-03-22 | $0.00 10-K · filed 2021-03-22 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 |